Antiepileptic Drugs: Pharmacology and Therapeutics: Handbook of Experimental Pharmacology, cartea 138
Editat de M. J. Eadie, F. Vajdaen Limba Engleză Paperback – 22 sep 2011
Din seria Handbook of Experimental Pharmacology
- 5% Preț: 1425.04 lei
- 5% Preț: 907.42 lei
- 5% Preț: 3517.78 lei
- 5% Preț: 730.30 lei
- 5% Preț: 1425.97 lei
- 5% Preț: 1435.28 lei
- 5% Preț: 1430.52 lei
- 5% Preț: 1930.69 lei
- 5% Preț: 1922.47 lei
- 5% Preț: 1937.46 lei
- 5% Preț: 2117.58 lei
- 5% Preț: 2119.96 lei
- 5% Preț: 2117.38 lei
- 5% Preț: 1088.15 lei
- 5% Preț: 1098.27 lei
- 5% Preț: 1420.29 lei
- 5% Preț: 1104.84 lei
- 5% Preț: 1104.84 lei
- 5% Preț: 1108.14 lei
- 5% Preț: 1106.69 lei
- 5% Preț: 1105.77 lei
- 5% Preț: 1174.35 lei
- 5% Preț: 408.48 lei
- 5% Preț: 409.63 lei
- 5% Preț: 539.89 lei
- 5% Preț: 720.47 lei
- 5% Preț: 733.09 lei
- 5% Preț: 731.27 lei
- 5% Preț: 746.43 lei
- 5% Preț: 747.72 lei
- 5% Preț: 725.24 lei
- 5% Preț: 742.80 lei
- 5% Preț: 393.23 lei
- 5% Preț: 735.66 lei
- 5% Preț: 728.33 lei
- 5% Preț: 389.52 lei
- 5% Preț: 730.71 lei
- 5% Preț: 740.58 lei
- 5% Preț: 730.19 lei
- 5% Preț: 723.42 lei
- 5% Preț: 731.27 lei
- 5% Preț: 726.68 lei
- 5% Preț: 3516.49 lei
- 5% Preț: 729.26 lei
- 5% Preț: 737.11 lei
- 5% Preț: 730.92 lei
- 5% Preț: 738.78 lei
- 5% Preț: 909.94 lei
- 5% Preț: 720.10 lei
Preț: 1114.91 lei
Preț vechi: 1173.60 lei
-5% Nou
Puncte Express: 1672
Preț estimativ în valută:
213.44€ • 222.70$ • 178.92£
213.44€ • 222.70$ • 178.92£
Carte tipărită la comandă
Livrare economică 12-26 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642642449
ISBN-10: 3642642446
Pagini: 676
Ilustrații: XXXVIII, 631 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 0.93 kg
Ediția:Softcover reprint of the original 1st ed. 1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642642446
Pagini: 676
Ilustrații: XXXVIII, 631 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 0.93 kg
Ediția:Softcover reprint of the original 1st ed. 1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
Professional/practitionerCuprins
1 Classification of Epileptic Seizures and the Epilepsies and Drugs of Choice for Their Treatment.- A. Introduction.- B. The International Classification of Epileptic Seizures.- C. Classification of the Epilepsies and Epileptic Syndromes.- D. Influence of Technological Advances on the Understanding of Semiology.- E. Drugs of Choice for Epileptic Seizures and the Epilepsies.- F. Conclusion.- References.- 2 Animal Models of Epilepsy and Epileptic Seizures.- A. Introduction.- B. Animal Models of Epilepsy.- C. Animal Models of Epileptic Seizures.- D. Conclusions.- References.- 3 Epileptogenesis: Electrophysiology.- A. Introduction.- B. Partial (Focal, or Lesional) Epilepsy.- C. Generalized Epilepsy: Absence Seizures.- D. Generalized Epilepsy: Convulsive Seizures.- References.- 4 Epileptogenesis: Biochemical Aspects.- A. Introduction.- B. Methods for Studying Epileptogenesis.- C. Role of Neurotransmitters in Epileptogenesis.- D. Postsynaptic Effects.- E. Neurotrophins and Neurogenesis.- F. Conclusions.- References.- 5 Cellular Actions of Antiepileptic Drugs.- A. Introduction.- B. Established Antiepileptic Drug Mechanisms of Action.- C. Newly Developed Antiepileptic Drug Mechanisms of Action.- References.- 6 The Search for New Anticonvulsants.- A. Introduction.- B. Pharmacological Strategies in the Search for New Anticonvulsants.- C. Clinical Evaluation of Preclinical Development Strategies.- D. Strategies for Future Drug Development.- E. Conclusions.- References.- 7 Measurement of Anticonvulsants and Their Metabolites in Biological Fluids.- A. Introduction.- B. Chromatographic Methods.- C. Capillary Electrophoresis and Micellar Electrokinetic Capillary Electrophoresis.- D. Stereoselective Drug Analysis.- E. Immunoassay Methods.- F. Free Drug Monitoring.- G. Quality Assurance.- References.- 8 Older Anticonvulsants Continuing in Use but with Limited Advance in Knowledge.- A. Introduction.- B. Phenobarbitone and Congeners.- C. Succinimides.- D. Sulthiame.- E. Acetazolamide.- F. Bromides.- References.- 9 Phenytoin and Congeners.- A. Phenytoin.- B. Fosphenytoin.- C. Mephenytoin.- D. Ethotoin.- E. Phenacetamide.- F. Albutoin.- References.- 10 Carbamazepine.- A. Introduction.- B. Chemistry and Use.- C. Pharmacodynamics.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- References.- 11 Oxcarbazepine.- A. Introduction.- B. Chemistry and Use.- C. Pharmacodynamics.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- References.- 12 Lamotrigine.- A. Introduction.- B. Chemistry and Use.- C. Pharmacodynamics.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- References.- 13 Valproate.- A. Introduction.- B. Chemistry and Use.- C. Pharmacodynamics.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- References.- 14 Vigabatrin.- A. Chemistry and Use.- B. Pharmacodynamics.- C. Pharmacokinetics.- D. Interactions.- E. Adverse Effects.- F. Use in Clinical Practice.- References.- 15 Benzodiazepines.- A. Introduction.- B. Pharmacodynamics of Benzodiazepines in General.- C. Benzodiazepine Adverse Effects and Their Mechanisms.- D. Diazepam.- E. Clobazam.- F. Clonazepam.- G. Lorazepam.- H. Nitrazepam.- I. Midazolam.- References.- 16 Gabapentin.- A. Introduction.- B. Chemistry and Use.- C. Pharmacodynamics.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- References.- 17 Tiagabine.- A. Introduction.- B. Chemistry and Use.- C. Pharmocodynamics.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- References.- 18 Topiramate.- A. Introduction.- B. Chemistry.- C. Pharmacodynamics.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- G. Clinical Use.- H. Conclusions.- References.- 19 Zonisamide.- A. Chemistry and Use.- B. Pharmacodynamics.- C. Pharmacokinetics.- D. Interactions.- E. Adverse Effects.- F. Dose and Administration.- References.- 20 Felbamate.- A. Introduction.- B. Chemistry and Use.- C. Pharmacodynamic Studies.- D. Pharmacokinetics.- E. Interactions.- F. Adverse Effects.- G. Use of Felbamate in Practice.- H. onclusions.- References.- 21 Drugs Under Clinical Trial.- A. Introduction.- B. Levetiracetam.- C Losigamone.- D. Remacemide.- E. Rufinamide.- F. Stiripentol.- G. Drugs in Early Clinical Development.- H. Conclusion.- References.- 22 Anticonvulsant Combinations and Interactions.- A. Introduction.- B. Extent of the Problem.- C. Pharmacokinetic Interactions.- D. Pharmacodynamic Interactions.- E. Interactions of the Generally Available Anticonvulsant Drugs.- F. Interactions of the Recently Licensed Anticonvulsant Drugs.- G. Conclusions.- References.- 23 The Use of Antiepileptic Drugs in Clinical Practice.- A. Introduction.- B. Changes in Antiepileptic Drug Use for Epilepsy.- C. The Decision to Prescribe Antiepileptic Drug Therapy.- D. The Choice of an Antiepileptic Drug.- E. Initiating Drug Therapy.- F. Continuing Drug Therapy.- G. Duration of Therapy.- H. Withdrawal of Therapy.- References.
Caracteristici
Includes supplementary material: sn.pub/extras